The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company�s products are used to treat arterial blockages in the heart and legs and to remove pacemaker and defibrillator cardiac leads. It offers excimer laser system known as the CVX-300. Its Vascular Intervention business unit includes a range of peripheral and cardiac laser catheters for ablation of lockages in arteries above and below the knee and within coronary arteries; support catheters to facilitate crossing of coronary and peripheral arterial blockages; therapeutic infusion system catheters for vascular delivery of drugs and diagnostic agents, and aspiration and thrombectomy catheters for the removal of thrombus. Lead Management business unit includes excimer laser sheaths, non-laser sheaths and cardiac lead management accessories for removal of problematic pacemaker and defibrillator cardiac leads.